News

Genomic and Medical research knowledge base powered by the blockchain and owned by its community, Luna DNA declared Dawn Barry as president. Barry will be held accountable for leading…
Read More...

U.S Stem Cell, Inc. claimed to be a leader in the development of proprietary stem cell therapies asserted accomplishing the target of 10,000 kit sales of proprietary Adipocell product,…
Read More...

Global biotech company committed to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, Castle Creek Pharmaceuticals confirmed…
Read More...

U.S FDA approves Teva Pharmaceutical's TRISENOX i.e. Arsenic trioxide injection amalgamated with  tretinoin  in the therapy of adults diagnosed with low -risk acute promyelocytic…
Read More...

Biopharmaceutical Company, Amcure insisted on extending its team of members by further appointing  Heinz Dieter Schwer, PhD, MBA, CEO of ViraTherapeutics. Klaus Dembowsky, MD, PhD,…
Read More...

Adaptimmune Therapeutics embarks on manufacturing T-cell therapy to treat  cancer entitled SPEAR T-cells for a patient at its Navy Yard facility in Philadelphia. In addition to this…
Read More...

Celgene Corporation and Impact Biomedicinessigned and agreement that entails acquisition of Impact Biomedicines enabling development of fedratinib  for myelofibrosis and polycythemia…
Read More...

Following the league of leading in the markets of  clinical research organizations, Optimapharm obtained Czech CRO company MKS research. Following the acquisition , Optimapharm will…
Read More...

Ipsen declared the appointment of Richard Paulson as Executive Vice-president and Chief Executive Officer of Ipsen North America accountable for  commercial operations throughout the…
Read More...

Concert Pharmaceuticals asserted that the U.S FDA has offered Fast Track designation for CTP-543, inhibitor for treatment of moderate-to severe Alopecia Areata discerned as a serious…
Read More...

Fresenius Kabi confirmed the availability of Bortezomib for injection  in the United States. Fresenius Kabi Bortezomib for Injection is available as a single dose vial containing 3.5 mg…
Read More...

GSK asserted that it has received approval from the US FDA center for biologics Evaluation and Research thereby hinting at the usage of FLUARIX QUADRIVALENT in persons 6 months and…
Read More...

FDA approved use of Lynparza (olaparib tablets) to include treatment of patients with certain types of  Breast Cancer that have become widespread and whose tumors possess inherited…
Read More...

Gobal open-access biologics technology platform company, Wuxi Biologics declares that Dr. Chiang Syin has been appointed by Wuxi Biologics as its Chief Quality Officer accountable for…
Read More...

Boston Scientific Corporation declared optimistic outcomes from the WHISPER randomized controlled Trial.According to the data presented at the 2018 Annual meeting of the North American …
Read More...

Private cancer drug discovery and development company, Sci- Engi-Medco Solutions Inc. (SEMCO) has secured a Small Business Innovation Research Phase 1 contract from the National Cancer…
Read More...

Clinical Biopharmaceutical Company Rgenix declared the Clinical and pre-Clinical results by research collaborators at Rgenix and Rockefeller University disclosing that Liver-X…
Read More...

Shiseido Company asserted that it has obtained Olivo Laboratories. Olivo is mainly a Polaris partners- based startup advancing the dermatological field through proprietary biomaterials…
Read More...

It is noteworthy that Ligand Pharmaceuticals entered into license agreement with Glenmark Pharmaceuticals to use Ligand's OmniAb platform including Omnichicken, Omnirat, OmniMouse and…
Read More...

Sarah Cannon entitled Johanna C. Bendell, MD, to Chief Development Officer. Her responsibilities encompass developing and expanding physician, site and Pharma relationships across the…
Read More...